Intermittent fasting and daily calorie restriction yield similar weight loss in 18-month obesity trial

An 18-month clinical trial involving more than 200 adults with obesity found that intermittent fasting led to about the same average weight loss as continuous calorie restriction after six months, while participants on the fasting plan reported less need to constantly monitor or restrict their eating.

More than 200 adults with obesity took part in an 18-month clinical trial run by researchers at the University of Adelaide. Participants were randomly assigned to one of three groups: intermittent fasting, continuous calorie restriction, or standard care.

Those in the intermittent fasting group consumed about 30% of their daily energy needs between 8 a.m. and 12 p.m. on three non-consecutive days each week, then completed a 20-hour fast. On the remaining days, they ate their usual diet. The continuous calorie-restriction group consumed about 70% of their normal calorie intake each day, while the standard-care group continued their regular diets and received healthy eating guidelines.

After six months, the intermittent-fasting and continuous-calorie-restriction groups had each lost an average of about seven kilograms, compared with about two kilograms in the standard-care group.

"While many diets can result in weight loss, they may be difficult to stick to and this makes keeping that weight off long-term more challenging," said Professor Leonie Heilbronn of Adelaide University’s School of Medicine and the South Australian Health and Medical Research Institute. She added that the findings suggest intermittent fasting "could offer an alternative pathway for people who find conventional dieting challenging."

Researchers reported that participants following intermittent fasting did not feel they had to constantly monitor their eating, avoid overeating, or count calories to achieve similar weight loss—an experience that differed from those assigned to continuous calorie restriction.

The findings were published in the journal Clinical Nutrition. The researchers said psychological and behavioral factors can influence whether people adhere to diets, and called for future trials designed to identify which individuals may benefit most from each approach.

Articoli correlati

Illustration of a study participant with brain scans and gut bacteria visuals related to intermittent fasting research.
Immagine generata dall'IA

Intermittent energy restriction tied to shifts in brain activity and gut microbiome, small study suggests

Riportato dall'IA Immagine generata dall'IA Verificato

A small 2023 study of adults with obesity in China found that an intermittent energy restriction program was associated with weight loss and changes in gut bacteria alongside altered activity in brain regions linked to appetite, cravings and self-control.

A seven-day water-only fast triggers major molecular shifts across the body, with the most significant effects emerging only after three days without food. Researchers tracked protein changes in healthy volunteers to map these responses in detail. The findings highlight both potential health benefits and risks of prolonged fasting.

Riportato dall'IA

A small clinical trial found that short periods of calorie restriction lowered inflammation markers tied to gum disease. Researchers at King's College London led the study involving patients in Spain. The results suggest dietary changes could complement standard dental treatments.

People who lose weight using GLP-1 medications such as Ozempic and Wegovy may be judged more negatively than those who lose weight through diet and exercise — and even more negatively than people who do not lose weight at all — according to a new study led by Rice University psychologist Erin Standen.

Riportato dall'IA Verificato

Many adults with type 2 diabetes who pause GLP-1 medications such as semaglutide (Ozempic) later resume treatment, according to research scheduled for presentation at ENDO 2026 in Chicago.

Questo sito web utilizza i cookie

Utilizziamo i cookie per l'analisi per migliorare il nostro sito. Leggi la nostra politica sulla privacy per ulteriori informazioni.
Rifiuta